Achieving Operating Profitability Early and Securing Investment Capacity
First written in FY2020. 3 of 13 entries say "Cited as achieved", first in FY2023. Latest entry: FY2026.
The whole theme swung hardest in 2026: 10 of 51 companies on the "Worse" side.
13 other companies' latest entry also says "Other".
- FY2026Operating profitability maintained, but full-year profit declinedAnnual report
「For the Group as a whole, we formulated the five-year medium-term management plan [TIAD６] starting from the next fiscal year. TIAD６ is positioned as a period for building the foundations for accelerated growth, with the aim of doubling corporate value and establishing the foundations for accelerated sustainable growth. The targets for the fiscal year ending June 2031 are operating income of ¥600 million, an operating margin of 25% and ROE of 15%.」
While operating profitability was maintained, operating income for the fiscal year under review was ¥209,911 thousand, down 15.9% year on year. From the next fiscal year onward, the company will transition to the targets of the new TIAD6 plan. - 2026-08-20RaisedEarnings presentation
「Operating profit ¥600 million Operating margin ≥25% ROE ≥15%」
The company raised its profitability targets from maintaining operating profitability to operating profit of ¥600 million, an operating margin of at least 25%, and ROE of at least 15%. - FY2026-H1Operating profitability maintained, but profit declinedAnnual report
「Operating income was ¥46,843 thousand, down 55.2% year on year, and ordinary income was ¥47,097 thousand, down 50.3%.」
The company maintained operating profitability, but operating income and ordinary income were below the levels of the same period of the previous year. - FY2025-H1Cited as achievedAnnual report
「Operating income was ¥104,603 thousand, up 46.2% year on year; ordinary income was ¥94,721 thousand, up 34.1%, due to the recognition of foreign exchange losses; and interim net income attributable to owners of the parent was ¥93,218 thousand, up 31.2%.」
The company recorded operating income of ¥104,603 thousand and maintained operating profitability in the interim period after returning to profitability in FY2021. - FY2024Cited as achievedAnnual report
「As a Group, we believe that we have progressed in transforming the company into one capable of generating profits on a sustained basis. While continuing to make the investments required for medium- to long-term growth, we will promote initiatives aimed at sustained growth in earnings.」
The company recorded operating income of ¥220,168 thousand and ordinary income of ¥241,441 thousand, citing its return to profitability and transformation into a profitable business as progress achieved to date, while indicating that it would continue growth investment and earnings growth. - FY2024-Q3RestatedAnnual report
「As a result, revenue for the third-quarter cumulative consolidated period increased 3.7% year on year to ¥1,115,556 thousand. Operating income was ¥251,940 thousand, down 4.2% year on year, due to increases in depreciation and maintenance expenses related to expanded facilities and higher research and development expenses, among other factors.」
The company recorded cumulative operating income of ¥251,940 thousand and maintained operating profitability, although this was down 4.2% year on year. - FY2024-Q1WorsenedAnnual report
「Operating loss was ¥30,728 thousand, compared with operating income of ¥1,433 thousand in the same period of the previous year; ordinary loss was ¥30,626 thousand, compared with ordinary income of ¥6,665 thousand; and net loss attributable to owners of the parent was ¥38,200 thousand, compared with a net loss attributable to owners of the parent of ¥17,599 thousand.」
Compared with the same period of the previous year following the achievement of early operating profitability, the first quarter recorded an operating loss and an ordinary loss, while the net loss also widened. - FY2023Cited as achievedAnnual report
「As a Group, we believe that we have progressed in transforming the company into one capable of generating profits on a sustained basis.」
After achieving operating profitability early, the company recorded operating income of ¥210,982 thousand and described its transformation into a company capable of generating profits on a sustained basis as progress achieved to date. - FY2021AchievedAnnual report
「As a result of efforts including reductions in selling, general and administrative expenses, operating income for the consolidated fiscal year under review was ¥39,368 thousand, compared with a loss of ¥17,039 thousand in the previous year; ordinary income was ¥59,503 thousand, compared with a loss of ¥16,502 thousand; and net income attributable to owners of the parent was ¥58,214 thousand, compared with a loss of ¥47,794 thousand. The company returned to profitability for the first time since the fiscal year ended March 2014.」
Against the goal of achieving operating profitability early, the company recorded full-year operating income of ¥39,368 thousand and returned to profitability at the operating, ordinary and net income levels. - FY2021-Q3RestatedAnnual report
「Although we continued efforts including reductions in selling, general and administrative expenses, operating income for the third-quarter cumulative consolidated period was ¥97,805 thousand, down 24.0% year on year, and ordinary income was ¥118,628 thousand, down 10.5%.」
The company continued reducing selling, general and administrative expenses and maintained operating profitability, but operating income and ordinary income declined year on year. - FY2021-Q2AdvancedAnnual report
「In addition, through efforts including reductions in selling, general and administrative expenses, we recorded operating income of ¥2,358 thousand for the first time for a second-quarter cumulative consolidated period, compared with an operating loss of ¥123,179 thousand in the same period of the previous year.」
In the second-quarter cumulative consolidated period, the company recorded operating income for the first time as it worked toward achieving operating profitability early. However, ordinary loss and net loss remained losses. - FY2021-Q1AdvancedAnnual report
「Operating loss was ¥36,104 thousand, compared with an operating loss of ¥89,246 thousand in the same period of the previous year; ordinary loss was ¥38,889 thousand, compared with an ordinary loss of ¥88,172 thousand; and net loss attributable to owners of the parent was ¥36,897 thousand, compared with a net loss attributable to owners of the parent of ¥88,629 thousand in the same period of the previous year.」
The operating loss narrowed from ¥89,246 thousand in the same period of the previous year to ¥36,104 thousand, indicating progress toward achieving operating profitability early. However, the company still reported an operating loss for the quarter. - FY2020First statedAnnual report
「The Group recognises the importance of achieving operating profitability early and increasing its capacity for investment in further development. To this end, we will seek to further expand and improve the profitability of the metabolomics business while commercialising the biomarker business, in which we have invested to date, at an early stage. At the same time, we will manage the company as a whole with due consideration to investment balance and work to enable balanced, sustainable growth.」
For the first time, the company independently identified early achievement of operating profitability as an explicit management priority, with expansion and improved profitability in the metabolomics business, early commercialisation of the biomarker business and balanced investment as the means of achieving it.